ARCHIVES

Preliminary Action Plan Seeks Consumer Representation

This article is from The Cancer Letter archive.

Vol. 20 No. 01 | January 7, 1994

Download PDF Visit The Full Archive

Related Articles

QOL With Femara Comparable To Placebo, Analysis Finds

December 26, 2003

Phase III Trial: Panobinostat Increases PFS by Four Months

September 26, 2014

Atrix, Sanofi In Marketing Deal For Leuprogel Products.

January 26, 2001

In Brief: HHS Finds Fisher, Wickerham, Redmond Did Not Commit Scientific Misconduct

March 7, 1997

GAO Report On NCI Cancer Control Contracts (Continued)

August 1, 1980

Cornel Student Withdraws In Wake Of Discrepancies Found In Study

September 18, 1981